Zhu Weiwei, Zhang Hua, Xing Yan
Pediatric Department, Peking University Third Hospital, Beijing 100191, China.
Clinical Epidemiology Research Center, Peking University Third Hospital, Beijing 100191, China.
Children (Basel). 2022 Jul 28;9(8):1126. doi: 10.3390/children9081126.
This study aimed to analyze clinical characteristics and risk factors for peripherally inserted central catheter (PICC) placement in premature infants.
This study included seven premature infants who were hospitalized in the neonatal intensive care unit (NICU) of Peking University Third Hospital from 1 January 2014-30 June 2021, and suffered PICC-related venous thrombosis. The control group included premature infants ( = 56) matched (1:8) by the following: Did not experience venous thrombosis; born with a similar gestational age (±2 w), birth weight (±200 g); and received PICC catheterization in the same period (±4 w). Clinical neonatal data were collected through the hospital electronic medical record system and analyzed using SPSS version 23.
The incidence of PICC-related thrombus was 0.23% (7/3043. Univariate analysis revealed that, compared to the non-thrombotic group, mothers in the thrombosis group had autoimmune diseases (χ = 9.844, = 0.030) and used anticoagulative drugs during pregnancy (χ = 8.036, = 0.025). The corrected gestational age when PICC-related thrombosis occurred in the thrombosis group was 32 + 6 (30 + 1, 34 + 1) weeks. The average time from catheter placement to thrombosis was 5 (1, 12) days. Among infants, 85.7% (6/7) experienced deep vein thrombosis, of which four were in the lower extremity veins; three occurred within 2 days after central venous catheter extubation, and four occurred during central venous catheter indwelling. The clinical manifestations of thrombosis include skin edema, color changes, and skin temperature changes in the affected limbs. The seven neonates had normal coagulation at the time of thrombus diagnosis, but D-dimers significantly increased 1-2 days after thrombosis, returning to normal 5-8 days after thrombus. The thrombus persisted for 4.5 (3, 8) days. All seven neonates were treated with low molecular weight heparin calcium anticoagulation for 10 (3, 17) days and recovered completely.
PICC-related thrombosis occurred within 1 week after catheter placement, and thrombosis more likely happened in infants whose mothers had autoimmune disease. When this high-risk factor exists and the patient has been intubated for 1 week and has sudden swelling in the intubated limb, venous ultrasound should be performed immediately to diagnose, and treatment should be provided in a timely manner to reduce adverse events.
本研究旨在分析早产儿经外周静脉穿刺中心静脉置管(PICC)的临床特征及危险因素。
本研究纳入了2014年1月1日至2021年6月30日在北京大学第三医院新生儿重症监护病房(NICU)住院且发生PICC相关静脉血栓形成的7例早产儿。对照组包括按以下条件(1:8)匹配的早产儿(n = 56):未发生静脉血栓形成;胎龄相似(±2周)、出生体重相似(±200 g);且在同一时期(±4周)接受PICC置管。通过医院电子病历系统收集临床新生儿数据,并使用SPSS 23版进行分析。
PICC相关血栓形成的发生率为0.23%(7/3043)。单因素分析显示,与非血栓形成组相比,血栓形成组的母亲患有自身免疫性疾病(χ² = 9.844,P = 0.030)且在孕期使用抗凝药物(χ² = 8.036,P = 0.025)。血栓形成组发生PICC相关血栓形成时的矫正胎龄为32 + 6(30 + 1,34 + 1)周。从置管到血栓形成的平均时间为5(1,12)天。在婴儿中,85.7%(6/7)发生深静脉血栓形成,其中4例位于下肢静脉;3例发生在中心静脉导管拔除后2天内,4例发生在中心静脉导管留置期间。血栓形成的临床表现包括患肢皮肤水肿、颜色改变和皮肤温度改变。7例新生儿在血栓诊断时凝血功能正常,但血栓形成后1 - 2天D - 二聚体显著升高,血栓形成后5 - 8天恢复正常。血栓持续4.5(3,8)天。所有7例新生儿均接受低分子肝素钙抗凝治疗10(3,17)天,且完全康复。
PICC相关血栓形成发生在置管后1周内,且母亲患有自身免疫性疾病的婴儿更易发生血栓形成。当存在这一高危因素且患者已插管1周且插管肢体突然肿胀时,应立即进行静脉超声检查以诊断,并及时给予治疗以减少不良事件。